In vivo, DHA inhibited the tumor growth of ESCC patient-derived xenografts and weakened p-mTOR, p-p70S6K, and p-RPS6 expression in tumor tissues. The gene discussed is MTOR; the disease is esophageal squamous cell carcinoma.